Seeing Is Believing
CLDX is currently covered by 6 analysts with an average price target of $101.54. This is a potential upside of $62.94 (163.06%) from yesterday's end of day stock price of $38.6.
Celldex Therapeutics's activity chart (see below) currently has 45 price targets and 60 ratings on display. The stock rating distribution of CLDX is 90.48% BUY, 4.76% SELL and 4.76% HOLD.
Analysts average stock forecasts to be materialized ratio is 21.34% with an average time for these price targets to be met of 54.73 days.
Highest price target for CLDX is $90, Lowest price target is $27, average price target is $101.54.
Most recent stock forecast was given by YATIN SUNEJA from GUGGENHEIM on 27-Feb-2024. First documented stock forecast 19-Dec-2008.
Currently out of the existing stock ratings of CLDX, 19 are a BUY (90.48%), 1 are a SELL (4.76%), 1 are a HOLD (4.76%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
90
$50.26 (126.47%)
72
1 months 21 days ago
0/4 (0%)
$38.96 (76.33%)
Hold
27
$-12.74 (-32.06%)
21
5 months 7 days ago
1/2 (50%)
$0.06 (0.22%)
4
Buy
80
$40.26 (101.31%)
73
5 months 11 days ago
6/15 (40%)
$50.65 (172.57%)
256
Buy
52
$12.26 (30.85%)
54
5 months 14 days ago
4/11 (36.36%)
$26.02 (100.15%)
62
Buy
68
$28.26 (71.11%)
70
8 months 6 days ago
0/3 (0%)
$37.77 (124.94%)
What is CLDX (Celldex Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CLDX (Celldex Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CLDX (Celldex Therapeutics)?
Which analyst is the currently most bullish on CLDX (Celldex Therapeutics)?
Which analyst is the currently most reserved on CLDX (Celldex Therapeutics)?